About Michael Rosenbluth
Michael Rosenbluth is a chief executive officer and director at Swing Therapeutics.
Michael Rosenbluth first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Rosenbluth in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Rosenbluth works with at each company, as listed on that company's latest Form D.
Swing Therapeutics, Inc. · Form D, Sep 15, 2025